Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
Adès L, Thomas X, Bresler AG, Raffoux E, Spertini O, Vey N, Marchand T, Récher C, Pigneux A, Girault S, Deconinck E, Gardin C, Tournilhac O, Lambert JF, Chevallier P, de Botton S, Lejeune J, Dombret H, Chevret S, Fenaux P.
Adès L, et al. Among authors: bresler ag.
Haematologica. 2018 Dec;103(12):2033-2039. doi: 10.3324/haematol.2018.198614. Epub 2018 Jul 19.
Haematologica. 2018.
PMID: 30026341
Free PMC article.
Clinical Trial.
Patients with newly diagnosed acute promyelocytic leukemia with a white blood cell count <10x10(9)/L, after an induction treatment consisting of all-trans retinoic acid plus idarubicin and cytarabine, received consolidation chemotherapy with idarubicin and cytarabine, a …
Patients with newly diagnosed acute promyelocytic leukemia with a white blood cell count <10x10(9)/L, after an induction treatment …